Challenges and Potential of Artificial Intelligence in Neuroradiology.

Abstract

Artificial intelligence (AI) has emerged as atransformative force in medical research and is garnering increased attention in the public consciousness. This represents acritical time period in which medical researchers, healthcare providers, insurers, regulatory agencies, and patients are all developing and shaping their beliefs and policies regarding the use of AI in the healthcare sector. The successful deployment of AI will require support from all these groups. This commentary proposes that widespread support for medical AI must be driven by clear and transparent scientific reporting, beginning at the earliest stages of scientific research. Areview of relevant guidelines and literature describing how scientific reporting plays acentral role at key stages in the life cycle of an AI software product was conducted. To contextualize this principle within aspecific medical domain, we discuss the current state of predictive tissue outcome modeling in acute ischemic stroke and the unique challenges presented therein. Translating AI methods from the research to the clinical domain is complicated by challenges related to model design and validation studies, medical product regulations, and healthcare providers' reservations regarding AI's efficacy and affordability. However, each of these limitations is also an opportunity for high-impact research that will help to accelerate the clinical adoption of state-of-the-art medical AI. In all cases, establishing and adhering to appropriate reporting standards is an important responsibility that is shared by all of the parties involved in the life cycle of aprospective AI software product.